Details, details 1989
Executive Summary
Bristol-Myers Squibb made 2.1 mil. sales calls last year, according to Scott-Levin's first full-year data from its monthly Personal Selling Audit tracking service. The "top individual" company was Merck with over 1.6 mil. sales calls, followed by Wyeth-Ayerst and Lilly, both with "just over" 1 mil. calls each. Glaxo's ulcer drug Zantac was the most heavily detailed product, logging 928,000 promotion calls. The number two and three spots were filled by Lilly's Ceclor and Glaxo's Ceftin. Hoffmann-LaRoche co-promotes both Zantac and Ceftin.